Five-Year Trend Analysis of Tuberculosis in Bahir Dar, Northwest Ethiopia, 2015–2019

Background: Tuberculosis (TB) remains a major cause of morbidity and mortality in Ethiopia despite the increased availability of effective treatments. Trend analysis of issues and priorities affecting TB programs across different regions of the country is critical to ensure equitable and sustainable TB outcomes. We aimed to analyze the trends of TB in Bahir Dar, Northwest Ethiopia, over 5 years from 2015 to 2019. Methods: An institution-based, retrospective cross-sectional study was conducted in Bahir Dar, the capital city of the Amhara Region in Ethiopia. Five-year data and records of individual TB cases were reviewed from all public and private health-care facilities and health bureaus in Bahir Dar. Using a standard checklist adapted from the World Health Organization, data were abstracted relevant to sociodemographic characteristics of the patients, year and type of TB infection, and HIV status. SPSS version 20 software was used for data analysis. Results: Data of 4275 patients with TB were identified, of which 929 (21.7%) were smear-positive pulmonary TB, 1195 (28%) were smear-negative pulmonary TB, and 2151 (50.3%) were extrapulmonary TB patients. TB was more prevalent in the age group 15–34 years (51.2%), and females (55.5%). In the years from 2015 to 2019, the prevalence of all forms of TB was 922 (21.6%), 812 (19.0%), 843 (19.7%), 876 (20.5%), and 822 (19.2%), respectively, demonstrating a decreasing trend though inconsistent. The variables sex (adjusted odds ratio [AOR]: 1.734, 95% confidence interval [CI] [1.390–2.187]), HIV co-infection (AOR: 1.875, 95% CI [1.553–2.265]), and age <15 years (AOR: 1.372, 95% CI [1.121–1.680]) showed a significant association with TB infection. Conclusions: The prevalence of TB in Bahir Dar, Northwest Ethiopia, demonstrated a decreasing trend over the years from 2015 to 2019 but with inconsistencies. HIV co-infection significantly increased the risk of developing TB, and productive age groups and females were at the greater prevalence of TB, highlighting the importance of strengthening sustainable TB care and prevention interventions toward these groups of people.

[1]  H. T. Menghistu,et al.  Neglected tropical zoonotic diseases in Tigray region, northern Ethiopia: Spatial distribution and trend analysis of rabies, tuberculosis, schistosomiasis, and visceral leishmaniasis in humans , 2021, Zoonoses and public health.

[2]  T. Manyazewal,et al.  Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis , 2021, Journal of clinical tuberculosis and other mycobacterial diseases.

[3]  Falaho Sani Kalil,et al.  Trends of Drug Resistance Tuberculosis from 2014 to 2018, Bale Zone, Oromia Region, Ethiopia , 2021, Infection and drug resistance.

[4]  A. Worku,et al.  Exploring community tuberculosis program in the pastoralist setting of Ethiopia: a qualitative study of community health workers’ perspectives in Borena Zone, Oromia Region , 2021, BMC Health Services Research.

[5]  G. Alene,et al.  Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia , 2021, PloS one.

[6]  T. Manyazewal,et al.  Molecular bacterial load assay versus culture for monitoring treatment response in adults with tuberculosis , 2021, SAGE open medicine.

[7]  V. Tiwari,et al.  Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host-Di-rected Therapies. , 2020, Current topics in medicinal chemistry.

[8]  Muluneh Alene,et al.  Patient delay in the diagnosis of tuberculosis in Ethiopia: a systematic review and meta-analysis , 2020, BMC Infectious Diseases.

[9]  Zemenu Tamir,et al.  Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia , 2020, Infection and drug resistance.

[10]  A. Fekadu,et al.  Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research , 2020, Infectious Diseases of Poverty.

[11]  T. Manyazewal,et al.  Bridging the gap between policy and practice: a qualitative analysis of providers’ field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia , 2020, BMJ Open.

[12]  V. Marconi,et al.  The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak , 2020, Nature Medicine.

[13]  V. Marconi,et al.  Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial , 2020, Trials.

[14]  B. Sapkota,et al.  Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis , 2020, Molecular Biology Reports.

[15]  A. Fekadu,et al.  Burden of tuberculosis and challenges related to screening and diagnosis in Ethiopia , 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

[16]  Hadush Negash,et al.  Six Years Trend Analysis of Tuberculosis in Northwestern Tigrai, Ethiopia; 2019: A Retrospective Study , 2020, Infection and drug resistance.

[17]  S. Yimer,et al.  Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia , 2019, PloS one.

[18]  Tewodros Tesfa,et al.  Trend Analysis And Seasonality Of Tuberculosis Among Patients At The Hiwot Fana Specialized University Hospital, Eastern Ethiopia: A Retrospective Study , 2019, Risk management and healthcare policy.

[19]  Hordofa Gutema,et al.  Trend in magnitude of tuberculosis in Awi Zone, Northwest Ethiopia: a five-year tuberculosis surveillance data analysis , 2019, BMC Research Notes.

[20]  S. Negash,et al.  Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia , 2018, PloS one.

[21]  F. Marinucci,et al.  Implementation and Evaluation of a Blended Learning Course on Tuberculosis for Front-Line Health Care Professionals , 2017, American journal of clinical pathology.

[22]  C. Dolea,et al.  World Health Organization , 1949, International Organization.